Molinaro A - Search Results

1

RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients.

Chakravarti A, Wang M, Robins HI, Lautenschlaeger T, Curran WJ, Brachman DG, Schultz CJ, Choucair A, Dolled-Filhart M, Christiansen J, Gustavson M, Molinaro A, Mischel P, Dicker AP, Bredel M, Mehta M. Chakravarti A, et al. Among authors: molinaro a. Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1206-11. doi: 10.1016/j.ijrobp.2012.10.008. Epub 2012 Nov 22. Int J Radiat Oncol Biol Phys. 2013. PMID: 23182702 Free PMC article. Clinical Trial.

2

AQUA analysis of thymidylate synthase reveals localization to be a key prognostic biomarker in 2 large cohorts of colorectal carcinoma.

Gustavson MD, Molinaro AM, Tedeschi G, Camp RL, Rimm DL. Gustavson MD, et al. Arch Pathol Lab Med. 2008 Nov;132(11):1746-52. doi: 10.5858/132.11.1746. Arch Pathol Lab Med. 2008. PMID: 18976010 Free article.

3

Evaluation of prognostic and predictive value of microtubule associated protein tau in two independent cohorts.

Baquero MT, Lostritto K, Gustavson MD, Bassi KA, Appia F, Camp RL, Molinaro AM, Harris LN, Rimm DL. Baquero MT, et al. Among authors: molinaro am. Breast Cancer Res. 2011 Nov 2;13(5):R85. doi: 10.1186/bcr2937. Breast Cancer Res. 2011. PMID: 21888627 Free PMC article.

4

Association of early changes in 1H MRSI parameters with survival for patients with newly diagnosed glioblastoma receiving a multimodality treatment regimen.

Nelson SJ, Kadambi AK, Park I, Li Y, Crane J, Olson M, Molinaro A, Roy R, Butowski N, Cha S, Chang S. Nelson SJ, et al. Among authors: molinaro a. Neuro Oncol. 2017 Mar 1;19(3):430-439. doi: 10.1093/neuonc/now159. Neuro Oncol. 2017. PMID: 27576874 Free PMC article.

5

Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma.

Molinaro AM, Hervey-Jumper S, Morshed RA, Young J, Han SJ, Chunduru P, Zhang Y, Phillips JJ, Shai A, Lafontaine M, Crane J, Chandra A, Flanigan P, Jahangiri A, Cioffi G, Ostrom Q, Anderson JE, Badve C, Barnholtz-Sloan J, Sloan AE, Erickson BJ, Decker PA, Kosel ML, LaChance D, Eckel-Passow J, Jenkins R, Villanueva-Meyer J, Rice T, Wrensch M, Wiencke JK, Oberheim Bush NA, Taylor J, Butowski N, Prados M, Clarke J, Chang S, Chang E, Aghi M, Theodosopoulos P, McDermott M, Berger MS. Molinaro AM, et al. JAMA Oncol. 2020 Apr 1;6(4):495-503. doi: 10.1001/jamaoncol.2019.6143. JAMA Oncol. 2020. PMID: 32027343 Free PMC article.

6

Using susceptibility-weighted imaging to determine response to combined anti-angiogenic, cytotoxic, and radiation therapy in patients with glioblastoma multiforme.

Lupo JM, Essock-Burns E, Molinaro AM, Cha S, Chang SM, Butowski N, Nelson SJ. Lupo JM, et al. Neuro Oncol. 2013 Apr;15(4):480-9. doi: 10.1093/neuonc/nos325. Epub 2013 Feb 7. Neuro Oncol. 2013. PMID: 23393208 Free PMC article.

7

A single-institution phase II trial of radiation, temozolomide, erlotinib, and bevacizumab for initial treatment of glioblastoma.

Clarke JL, Molinaro AM, Phillips JJ, Butowski NA, Chang SM, Perry A, Costello JF, DeSilva AA, Rabbitt JE, Prados MD. Clarke JL, et al. Among authors: molinaro am. Neuro Oncol. 2014 Jul;16(7):984-90. doi: 10.1093/neuonc/nou029. Neuro Oncol. 2014. PMID: 24637230 Free PMC article. Clinical Trial.

8

Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab.

Wen Q, Jalilian L, Lupo JM, Molinaro AM, Chang SM, Clarke J, Prados M, Nelson SJ. Wen Q, et al. J Neurooncol. 2015 Jan;121(2):331-9. doi: 10.1007/s11060-014-1636-6. Epub 2014 Oct 29. J Neurooncol. 2015. PMID: 25351579 Free PMC article.

9

Serial analysis of 3D H-1 MRSI for patients with newly diagnosed GBM treated with combination therapy that includes bevacizumab.

Nelson SJ, Li Y, Lupo JM, Olson M, Crane JC, Molinaro A, Roy R, Clarke J, Butowski N, Prados M, Cha S, Chang SM. Nelson SJ, et al. Among authors: molinaro a. J Neurooncol. 2016 Oct;130(1):171-179. doi: 10.1007/s11060-016-2229-3. Epub 2016 Aug 17. J Neurooncol. 2016. PMID: 27535746 Free PMC article.

10

Identifying Voxels at Risk for Progression in Glioblastoma Based on Dosimetry, Physiologic and Metabolic MRI.

Anwar M, Molinaro AM, Morin O, Chang SM, Haas-Kogan DA, Nelson SJ, Lupo JM. Anwar M, et al. Among authors: molinaro am. Radiat Res. 2017 Sep;188(3):303-313. doi: 10.1667/RR14662.1. Epub 2017 Jul 19. Radiat Res. 2017. PMID: 28723274 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

703 results

Search Page

Filters